FIELD: medicine.
SUBSTANCE: invention is related to a complex antiangiogenic and hypoxia-oriented antitumor agent containing the chemical compound 1-cyclohexanoyl-2-ethylisothioureaα-cyano-4-hydroxycinnamate as an active substance of general formula (I), which has NOS-inhibitory and MCT-inhibitory activity and has a combined antiangiogenic and hypoxia-oriented toxic effect on neoplasia.
EFFECT: complex antiangiogenic and hypoxia-oriented antitumor agent that provides a more pronounced, stable and long-lasting antitumor effect against neoplasia of various histogenesis, without increasing toxic effects.
2 cl, 3 tbl, 3 ex
(I)
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
ANTICANCER AGENT | 2012 |
|
RU2503450C1 |
METHOD OF PROTON THERAPY FOR SOLID EHRLICH CARCINOMA | 2023 |
|
RU2808984C1 |
INDOL-3-CARBOXIC ACID DERIVATIVES WITH ANTI-TUMOR ACTIVITY | 2022 |
|
RU2782931C2 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
METHOD FOR MODIFYING PHOTODYNAMIC THERAPY | 2010 |
|
RU2449821C1 |
NANOPARTICLE BASED, TUMOUR-TARGETED DELIVERY OF MEDICINAL AGENTS | 2011 |
|
RU2593367C2 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
Authors
Dates
2023-10-05—Published
2022-10-04—Filed